Muscle Relaxants Drugs Industry Strategic Developments to 2036
healthcare providers seek safer options, especially given the heightened regulatory scrutiny of opioid prescriptions and the growing concerns regarding addiction risks. North America leads the market thanks to its advanced healthcare infrastructure and high disease burden